J C Jonas1, Y Guiot, J Rahier, J C Henquin. 1. Unit of Endocrinology and Metabolism, Faculty of Medicine, University of Louvain, Brussels, Belgium. jonas@endo.ucl.ac.be [corrected]
Abstract
AIM/HYPOTHESIS: Increased expression of haeme-oxygenase 1 (HO1) and other antioxidant enzymes could improve pancreatic beta-cell survival under stressful conditions, including hyperglycaemia. However, how hyperglycaemia increases islet HO1 expression is not known. METHODS: Rat islets were pre-cultured for 1 week in RPMI medium containing 10 mmol x l(-1) glucose (G10), and further cultured overnight in G5-G30 plus various test substances. Islet HO1 mRNA and protein expression was measured by semiquantitative RT-PCR, western blot, and immunohistochemistry. RESULTS: Islet HO1 mRNA expression was minimal after overnight culture in G10, slightly increased in G5, and increased by five- to ten-fold in G30 in parallel with a heterogeneous increase in beta-cell HO1 protein expression. The effect of G30 was fully inhibited by agents decreasing cytosolic Ca2+ (diazoxide, nimodipine), but was only slightly reproduced by agents raising Ca2+ (tolbutamide, 30 mmol x l(-1) potassium). It was also suppressed by the alpha2-adrenoceptor agonist clonidine, whereas dibutyryl-cyclic-AMP largely increased beta-cell HO1 expression. The induction of HO1 mRNA expression by G30 was independent from changes in medium insulin concentration, but was completely inhibited by a cocktail of antioxidants. In contrast to HO1, islet mRNA expression of glutathione peroxidase and constitutive haeme-oxygenase 2 were not affected by G30, nor by dibutyryl-cyclic-AMP. CONCLUSION/ INTERPRETATION: High glucose and dibutyryl-cyclic-AMP stimulate expression of HO1 in rat pancreatic beta cells. The inhibition of HO1 expression in G30 by nimodipine, clonidine, and antioxidants, suggests that Ca2+ influx and cyclic-AMP are necessary for the generation of oxidative stress by G30, or for the stimulation of beta-cell HO1 expression by increased oxidative stress.
AIM/HYPOTHESIS: Increased expression of haeme-oxygenase 1 (HO1) and other antioxidant enzymes could improve pancreatic beta-cell survival under stressful conditions, including hyperglycaemia. However, how hyperglycaemia increases islet HO1 expression is not known. METHODS:Rat islets were pre-cultured for 1 week in RPMI medium containing 10 mmol x l(-1) glucose (G10), and further cultured overnight in G5-G30 plus various test substances. Islet HO1 mRNA and protein expression was measured by semiquantitative RT-PCR, western blot, and immunohistochemistry. RESULTS: Islet HO1 mRNA expression was minimal after overnight culture in G10, slightly increased in G5, and increased by five- to ten-fold in G30 in parallel with a heterogeneous increase in beta-cell HO1 protein expression. The effect of G30 was fully inhibited by agents decreasing cytosolic Ca2+ (diazoxide, nimodipine), but was only slightly reproduced by agents raising Ca2+ (tolbutamide, 30 mmol x l(-1) potassium). It was also suppressed by the alpha2-adrenoceptor agonist clonidine, whereas dibutyryl-cyclic-AMP largely increased beta-cell HO1 expression. The induction of HO1 mRNA expression by G30 was independent from changes in medium insulin concentration, but was completely inhibited by a cocktail of antioxidants. In contrast to HO1, islet mRNA expression of glutathione peroxidase and constitutive haeme-oxygenase 2 were not affected by G30, nor by dibutyryl-cyclic-AMP. CONCLUSION/ INTERPRETATION: High glucose and dibutyryl-cyclic-AMP stimulate expression of HO1 in ratpancreatic beta cells. The inhibition of HO1 expression in G30 by nimodipine, clonidine, and antioxidants, suggests that Ca2+ influx and cyclic-AMP are necessary for the generation of oxidative stress by G30, or for the stimulation of beta-cell HO1 expression by increased oxidative stress.
Authors: J C Jonas; D R Laybutt; G M Steil; N Trivedi; J G Pertusa; M Van de Casteele; G C Weir; J C Henquin Journal: J Biol Chem Date: 2001-07-16 Impact factor: 5.157
Authors: D Ross Laybutt; Hideaki Kaneto; Wendy Hasenkamp; Shane Grey; Jean-Christophe Jonas; Dennis C Sgroi; Adam Groff; Christiane Ferran; Susan Bonner-Weir; Arun Sharma; Gordon C Weir Journal: Diabetes Date: 2002-02 Impact factor: 9.461
Authors: J C Jonas; A Sharma; W Hasenkamp; H Ilkova; G Patanè; R Laybutt; S Bonner-Weir; G C Weir Journal: J Biol Chem Date: 1999-05-14 Impact factor: 5.157
Authors: Matthew Nayor; Danielle M Enserro; Alexa S Beiser; Susan Cheng; Charles DeCarli; Ramachandran S Vasan; Sudha Seshadri Journal: Stroke Date: 2015-12-22 Impact factor: 7.914
Authors: H Elouil; M Bensellam; Y Guiot; D Vander Mierde; S M A Pascal; F C Schuit; J C Jonas Journal: Diabetologia Date: 2007-05-12 Impact factor: 10.122